pimicotinib

Shanghai, China, November 11, 2026 Abbisko Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has approved...

Shanghai, China – April 22, 2026 In a major milestone for rare tumor therapeutics, Abbisko Therapeutics has announced significant...